Company Profile
Syndax Pharmaceuticals Stock Price, News & Analysis
- Ticker:
- SNDX
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in Waltham, Massachusetts and listed on NASDAQ, Syndax is followed within the oncology universe for its exposure to catalyst-driven development and launch events.
Stock performance
19.61 USD (+1.50%)
Close
Last updated: June 23, 2026 at 00:00
1.74B USD
Market cap
Why the stock is moving
SNDX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Syndax Pharmaceuticals is an oncology company focused on targeted therapies and hematologic disease opportunities. Investors watch trial readouts, regulatory milestones, and how the company converts its pipeline into commercial traction.
Geographic Base and Sector Classification
Headquartered in Waltham, Massachusetts and listed on NASDAQ, Syndax is followed within the oncology universe for its exposure to catalyst-driven development and launch events.
Business Model Characteristics
Syndax follows a pipeline-and-launch model where data quality, approval timing, and market access determine how quickly the company can scale.
Position Within the Biotechnology Landscape
Compared with larger oncology peers, Syndax sits closer to the development side of the landscape, where each major update can move expectations quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Syndax Showcases Revuforj® (revumenib) Clinical Activity in Multiple Acute Leukemia Subtypes and Settings at EHA 2026
Source: Syndax Pharmaceuticals
- 02
- 03
Syndax Announces Private Placement of $250.0 Million of Convertible Senior Notes
Source: Syndax Pharmaceuticals
- 04
- 05
Syndax to Host R&D Day Highlighting its Late-Stage Programs and Early-Stage Assets on July 14, 2026
Source: Syndax Pharmaceuticals
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Syndax Pharmaceuticals (SNDX)?
Syndax Pharmaceuticals (SNDX) most recently closed at 19.61 USD, a +1.50% move versus the previous session.
What is the market cap of Syndax Pharmaceuticals (SNDX)?
Syndax Pharmaceuticals currently has a market capitalization of 1.74B USD on BioPharmSignal.
What does Syndax Pharmaceuticals do?
Syndax Pharmaceuticals is an oncology company focused on targeted therapies and hematologic disease opportunities. Investors watch trial readouts, regulatory milestones, and how the company converts its pipeline into commercial traction.
On which exchange is SNDX stock listed?
Syndax Pharmaceuticals (SNDX) is associated with NASDAQ, Headquartered in Waltham, Massachusetts and listed on NASDAQ, Syndax is followed within the oncology universe for its exposure to catalyst-driven development and launch events., Biotechnology.
What is Syndax?
Syndax Pharmaceuticals is an oncology company focused on targeted therapies and hematologic disease opportunities.
Which conditions is Syndax Pharmaceuticals targeting with Syndax?
Syndax Pharmaceuticals is associated with oncology based on its company overview and current catalyst commentary.
What is Pharmaceuticals?
Syndax Pharmaceuticals is an oncology company focused on targeted therapies and hematologic disease opportunities.
What is Investors?
Investors watch trial readouts, regulatory milestones, and how the company converts its pipeline into commercial traction.